There are many unknowns, and more investigation is needed to understand the full impact

Photo illustration by the author; Virus image: by Gerd Altman via Pixabay

A new variant, B.1.1.529, which no one had heard of until a few days ago, has the whole world in jitters. It was first detected in Botswana and identified by South Africa on Nov. 25, 2021. The next day, the World Health Organization that(WHO) classified this new variant, B.1.1.529, as…

If the FDA grants emergency use authorization for the drug, it could become available in the U.S. by next year

Pfizer Logo, Public domain, via Wikimedia Commons; Pills, Photo by Hal Gatewood on Unsplash

Pfizer has been conducting a randomized, double-blind study of their antiviral pill to a cohort of 1,881 non-hospitalized adult patients with COVID-19. They were all at high risk of progressing to severe illness. On Nov. …

FDA and CDC clear Pfizer and Moderna shots for all adults

Photo by CDC on Unsplash

The much-anticipated news from the FDA about boosters for all adults was announced early Friday (Nov. 19, 2021) morning by Pfizer and Moderna. “This emergency use authorization comes at a critical time as we enter the winter months and face increasing COVID-19 case counts and hospitalizations across the country,” Moderna…

Your child can get the first jab of the vaccine now in a nearby pharmacy

Photo by CDC on Unsplash

The CDC Advisory Committee of Immunization Practices (ACIP) has unanimously recommended approval of the vaccine for kids, 5–11 years old on Tuesday, Nov. 2. The Director of CDC, Dr. Rochelle Wallensky, has signed off on the recommendation. This follows the FDA’s emergency use authorization (EUA) of the COVID-19 vaccine from…

If the FDA grants emergency use authorization for the drug, it could become available in the U.S. before the end of the year

Photo illustration by the author, Molnupirvar image via ACS-C&EN

The health regulators in the U.K., on Nov. 4, said Merck’s molnupiravir is safe and effective and cleared its use for treating COVID-19. Merck & Co. partnered with Ridgeback Biotherapeutics L.P. to manufacture the drug. Drug Innovation Ventures at Emory (DRIVE), a not-for-profit biotechnology company wholly owned by Emory University

Democrats have only a razor-thin majority, and three lawmakers hold the key in shaping the outcome

Public domain images via Wikimedia Commons: Jayapal, Manchin, Sinema

Rep. Pramila Jayapal (D-Wash.) is the chair of the Congressional Progressive Caucus, the 96 member-strong left-leaning body in the U.S. Congress. As the Democrats strive to finalize a sweeping Build Back Better bill, an extensive climate, and social spending package, her leadership has been crucial in crafting a compromise. Two…

Parents can expect a rollout of the vaccine in early November

Photo by CDC on Unsplash

The FDA’s expert panel, Vaccines, and Related Biological Products Advisory Committee that met yesterday, Oct. 26, has recommended that the agency issue an emergency use authorization (EUA) of the COVID-19 vaccine from Pfizer/BioNTech in young children.

Last week, the FDA said the companies’ late-stage study results met the criteria for…

Americans now have a choice of three booster shots: Pfizer, Moderna, and Johnson & Johnson

Photo illustration by the author; Janssen Image via Shutterstock, Artist: PCRUCIATTI

On Thursday, Oct. 21, scientific advisors to the CDC agreed to the FDA’s authorization of Moderna and Johnson & Johnson (J&J) booster shots, a decision the Director, Dr. Rochelle Wallensky, later endorsed. A third shot of the Pfizer vaccine has been available in the U.S. since Sept. 22. Now every…

Any mask is better than no mask; the one that tightly fits the face works best

Photo illustration by the author; Images, Trophy, Mountains via Pixabay

If one had read or listened to the latest news of COVID-19 infections, it would have said that COVID-19 cases are declining. The news reports come with a caveat that while the overall case numbers are declining, they remain high in some northern states. The U.S. daily average numbers are…

Given new evidence, would the CDC delay the second dose to children, 5–11, when the Pfizer vaccine is approved?

Photo illustration by the author. Royalty-Free Image of Canada Via Free U.S. & World Map

The COVID -19 vaccines available to Canada to inoculate its citizens were Oxford/AstraZeneca and the two mRNA formulations, Pfizer/BioNTech and Moderna. Citing cases where local supply shortages or health concerns might prevent some persons from completing their two-dose regimen, in June 2021, the National Advisory Committee on Immunization (NACI) changed…

Dr. Zach Zachariah

Ph.D. chemist with an M.B.A. | Enrolled Agent | Writes on science | economy | taxes | public interest topics | American politics | Indian-Americans | COVID-19

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store